NCT01645774

Brief Summary

Subcutaneous heparin injection is one of the most frequent nurses' clinical care. This study aimed to Identify and compare the effects of four different injection duration on pain and bruising associated with subcutaneous injection of heparin in 90 patients. Four injection methods were used for them: A: 10s injections duration B: 10s injection duration and waiting 10s before withdrawing the needle C: 15s injection duration and waiting 5s before withdrawing the needle D: 5s injection duration and waiting 15s before withdrawing the needle. Bruising was measured by a flexible millimeter ruler 48h after each injection; and pain was measured by pain visual analogue scale immediately after the injection. Data will be analyzed by SPSS.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for phase_2 pain

Timeline
Completed

Started Jan 2011

Typical duration for phase_2 pain

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2011

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

May 19, 2012

Completed
13 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2012

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 20, 2012

Completed
Last Updated

July 20, 2012

Status Verified

June 1, 2012

Enrollment Period

1.4 years

First QC Date

May 19, 2012

Last Update Submit

July 19, 2012

Conditions

Keywords

subcutaneous injection heparininjection durationbruising paindecrease paindecrease bruising

Outcome Measures

Primary Outcomes (2)

  • decrease pain

    pain was measured by pain visual analogue scale immediately after the injection.

    up to 6 months

  • bruising

    Bruising was measured by a flexible millimeter ruler 48h after each injection

    up to 6 months

Study Arms (4)

10s injections duration

EXPERIMENTAL

10s injections duration

Procedure: 10s injections duration

10s injection duration , waiting 10s

EXPERIMENTAL

10s injection duration and waiting 10s before withdrawing the needle

Procedure: 10s injection duration and waiting 10s before withdrawing the needle

15s injection duration,waiting 5s

EXPERIMENTAL

15s injection duration and waiting 5s before withdrawing the needle

Procedure: 15s injection duration and waiting 5s before withdrawing the needle

5s injection duration , waiting 15s

EXPERIMENTAL

5s injection duration and waiting 15s before withdrawing the needle

Procedure: 5s injection duration and waiting 15s before withdrawing the needle

Interventions

10s injections duration

10s injections duration

10s injection duration and waiting 10s before withdrawing the needle

10s injection duration , waiting 10s

15s injection duration and waiting 5s before withdrawing the needle

15s injection duration,waiting 5s

5s injection duration and waiting 15s before withdrawing the needle

5s injection duration , waiting 15s

Eligibility Criteria

Age53 Years - 69 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Inclination to participate in the study; filling out the form of conscious satisfaction
  • Ability to answer the questions and determining the rate of pain
  • Not being affected by blood clotting difficulties, tissue damages, injuries, and bruises in the site of injection.

You may not qualify if:

  • Death,
  • Discharge

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

PainContusions

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsWounds, NonpenetratingWounds and Injuries

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
faculty member,MSc of Nursing

Study Record Dates

First Submitted

May 19, 2012

First Posted

July 20, 2012

Study Start

January 1, 2011

Primary Completion

June 1, 2012

Study Completion

June 1, 2012

Last Updated

July 20, 2012

Record last verified: 2012-06